Frequent Chronic Obstructive Pulmonary Disease Exacerbators: How Much Real, How Much Fictitious?

被引:40
作者
Jose Soler-Cataluna, Juan [1 ]
Rodriguez-Roisin, Roberto [2 ]
机构
[1] Hosp Gen Requena, Internal Med Serv, Pneumol Unit, Valencia, Spain
[2] Univ Barcelona, Hosp Clin, IDIBAPS, Serv Pneumol,Inst Torax, Barcelona, Spain
关键词
Daily life activities; Definition; Frequency; Lung function; Mortality; Quality of life; LUNG-FUNCTION DECLINE; QUALITY-OF-LIFE; COPD EXACERBATIONS; HEALTH-STATUS; RISK-FACTORS; TIME-COURSE; IMPACT; MORTALITY; RECOVERY; AIRWAY;
D O I
10.3109/15412555.2010.496817
中图分类号
R56 [呼吸系及胸部疾病];
学科分类号
摘要
Exacerbations are important events in the natural history of chronic obstructive pulmonary disease (COPD). The higher the number of COPD exacerbations, the worse are the clinical and economical consequences. The distribution of COPD exacerbations is however highly variable. Some patients do not exhibit exacerbations at all whereas others suffer frequent events (i.e., "frequent COPD exacerbators"). We review the scientific evidence regarding the impact of COPD exacerbation frequency and assess whether or not these frequent exacerbators represent a unique population of COPD patients with higher morbidity and mortality risks. A definition of "frequent COPD exacerbators" is suggested to differentiate it from other related terms, such as "treatment failure" and "recurrence." The standardization of this terminology seems to be necessary to further identify COPD phenotypes in patients who have an individual susceptibility to develop frequent exacerbations. It can also be of help to refine the most appropriate therapeutic and preventative measures.
引用
收藏
页码:276 / 284
页数:9
相关论文
共 60 条
[1]   Counting, analysing and reporting exacerbations of COPD in randomised controlled trials [J].
Aaron, S. D. ;
Fergusson, D. ;
Marks, G. B. ;
Suissa, S. ;
Vandemheen, K. L. ;
Doucette, S. ;
Maltais, F. ;
Bourbeau, J. F. ;
Goldstein, R. S. ;
Balter, M. ;
O'Donnell, D. ;
FitzGerald, M. .
THORAX, 2008, 63 (02) :122-128
[2]   Tiotropium in combination with placebo, salmeterol, or fluticasone-salmeterol for treatment of chronic obstructive pulmonary disease - A randomized trial [J].
Aaron, Shawn D. ;
Vandemheen, Katherine L. ;
Fergusson, Dean ;
Maltais, Francois ;
Bourbeau, Jean ;
Goldstein, Roger ;
Balter, Meyer ;
O'Donnell, Denis ;
McIvor, Andrew ;
Sharma, Sat ;
Bishop, Graham ;
Anthony, John ;
Cowie, Robert ;
Field, Stephen ;
Hirsch, Andrew ;
Hernandez, Paul ;
Rivington, Robert ;
Road, Jeremy ;
Hoffstein, Victor ;
Hodder, Richard ;
Marciniuk, Darcy ;
McCormack, David ;
Fox, George ;
Cox, Gerard ;
Prins, Henry B. ;
Ford, Gordon ;
Bleskie, Dominique ;
Doucette, Steve ;
Mayers, Irvin ;
Chapman, Kenneth ;
Zamel, Noe ;
FitzGerald, Mark .
ANNALS OF INTERNAL MEDICINE, 2007, 146 (08) :545-U15
[3]   Association of left-heart dysfunction with severe exacerbation of chronic obstructive pulmonary disease - Diagnostic performance of cardiac biomarkers [J].
Abroug, Fekri ;
Ouanes-Besbes, Lamia ;
Nciri, Noureddine ;
Sellami, Noura ;
Addad, Faouz ;
Ben Hamda, Khaldoun ;
Ben Amor, Adel ;
Najjar, Mohamed F. ;
Knani, Jalel .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2006, 174 (09) :990-996
[4]   Mortality after hospitalization for COPD [J].
Almagro, P ;
Calbo, E ;
de Echagüen, AO ;
Barreiro, B ;
Quintana, S ;
Heredia, JL ;
Garau, J .
CHEST, 2002, 121 (05) :1441-1448
[5]   The costs of exacerbations in chronic obstructive pulmonary disease (COPD) [J].
Andersson, F ;
Borg, S ;
Jansson, SA ;
Jonsson, AC ;
Ericsson, Å ;
Prütz, C ;
Rönmark, E ;
Lundbäck, B .
RESPIRATORY MEDICINE, 2002, 96 (09) :700-708
[6]   ANTIBIOTIC-THERAPY IN EXACERBATIONS OF CHRONIC OBSTRUCTIVE PULMONARY-DISEASE [J].
ANTHONISEN, NR ;
MANFREDA, J ;
WARREN, CPW ;
HERSHFIELD, ES ;
HARDING, GKM ;
NELSON, NA .
ANNALS OF INTERNAL MEDICINE, 1987, 106 (02) :196-204
[7]   Relation of sputum inflammatory markers to symptoms and lung function changes in COPD exacerbations [J].
Bhowmik, A ;
Seemungal, TAR ;
Sapsford, RJ ;
Wedzicha, JA .
THORAX, 2000, 55 (02) :114-120
[8]   Impact on patients' health status following early identification of a COPD exacerbation [J].
Bourbeau, J. ;
Ford, G. ;
Zackon, H. ;
Pinsky, N. ;
Lee, J. ;
Ruberto, G. .
EUROPEAN RESPIRATORY JOURNAL, 2007, 30 (05) :907-913
[9]   COPD exacerbations: definitions and classifications [J].
Burge, S ;
Wedzicha, JA .
EUROPEAN RESPIRATORY JOURNAL, 2003, 21 :46S-53S
[10]   Cough and Sputum Production Are Associated With Frequent Exacerbations and Hospitalizations in COPD Subjects [J].
Burgel, Pierre-Regis ;
Nesme-Meyer, Pascale ;
Chanez, Pascal ;
Caillaud, Denis ;
Carre, Philippe ;
Peres, Thierry ;
Roche, Nicolas .
CHEST, 2009, 135 (04) :975-982